Latest News
Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.
/PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the 'Healthcare Resource Utilization and Costs Associated
Bellway builds more home and cash despite tough market
Bellway PLC (LSE:BWY) has delivered a stronger-than-expected year, with housing completions up 10.8% and operating cash flow beating its previous guidance. The housebuilder completed 9,695 homes in th
LX Pantos refuerza su liderazgo global en ESG a través de su Informe de Sostenibilidad 2026
/PRNewswire/ -- LX Pantos (director general y consejero delegado: Lee Yong-ho) ha publicado su Informe de Sostenibilidad 2026, en el que destaca los avances
Hexcel's Margin Breakout Is Becoming Hard To Ignore
Hexcel Corporation demonstrates accelerating operating leverage, with Q2 sales up 8% and adjusted operating margin expanding 280 bps to 13.9%. HXL raises 2026 sales and EPS guidance, reflecting broade
Restaurant Brands International: Burger King Is Turning Up The Heat
Restaurant Brands International is upgraded to a buy as Burger King's turnaround drives market share gains over McDonald's. QSR's valuation has improved, with a TTM PE of 18.5 and low FCF growth requi
Intel Joins Race To Sell Shares At Sky-High Prices After Spike - Big Tech Figured It Out, The Economy Benefits, Maybe Not Investors
Vast amounts of cash get moved from Investors to Big Tech via equity and debt sales to be spent in the real economy. Intel announced on Monday that it plans an offering of $15 billion in common stock.
FiscalNote Holdings, Inc. (NOTE) Q2 2026 Earnings Call Prepared Remarks Transcript
FiscalNote Holdings, Inc. (NOTE) Q2 2026 Earnings Call Prepared Remarks Transcript
Radcom: Guidance Was Cut, But I'm Still Bullish
RADCOM Ltd. faces a significant revenue guidance cut for 2026, now expecting $57–$63 million, down from the prior $78.6 million midpoint. Despite the setback, RDCM's valuation at $10 per share and $60
Archer Aviation Exec Says Boeing Deal Will ‘Significantly Change the Profile' as $200 Million Insitu Business Joins Portfolio
Archer Aviation Inc.‘s (NYSE:ACHR) deal with Boeing Co. (NYSE:BA) could significantly reshape the electric vertical take-off and landing (eVTOL) company.
Archer Aviation Inc. (ACHR) Q2 2026 Earnings Call Transcript
Archer Aviation Inc. (ACHR) Q2 2026 Earnings Call Transcript
Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Cardinal Health, Inc. (NYSE:CAH) will release its fourth quarter earnings report before the opening bell on Tuesday, Aug. 11.
Tenax LEVEL Trial Misses Primary Goal, but Subgroup Data Bolsters Levosimendan Case
Tenax Therapeutics NASDAQ: TENX reported that its Phase III LEVEL trial of oral levosimendan in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction, or
Meridian Drills Multiple, Stacked Layers of Gold-Copper-Silver and Zinc-Lead VMS Mineralisation Below Santa Helena
Highlights: Lower zone of multiple stacked layers of Au-Cu-Ag & Zn-Pb VMS mineralisation drilled at Santa Helena; — CD-878's upper layer drills 11.3m @ 0.8g/t Au, 0.2% Cu, 17.6g/t Ag, 3.4% Zn & 0.6%
Hims & Hers Health, Inc. (HIMS) Q2 2026 Earnings Call Transcript
Hims & Hers Health, Inc. (HIMS) Q2 2026 Earnings Call Transcript
Insight Molecular Diagnostics Inc. (IMDX) Q2 2026 Earnings Call Transcript
Insight Molecular Diagnostics Inc. (IMDX) Q2 2026 Earnings Call Transcript
Amotiv Limited (GUDDY) Q4 2026 Earnings Call Transcript
Amotiv Limited (GUDDY) Q4 2026 Earnings Call Transcript
SunocoCorp: Parkland Synergies And Cash Flow Growth Drive Upside
Sunoco LP has transformed into a diversified multinational platform, integrating fuel distribution, pipelines, terminals, convenience stores, and refining assets. Q2 2026 results showed net income of
Exodus Movement, Inc. (EXOD) Q2 2026 Earnings Call Transcript
Exodus Movement, Inc. (EXOD) Q2 2026 Earnings Call Transcript
Pampa Energia: Rincon De Aranda And Fertilizers Add New Legs To The Bull Case
Pampa Energia's Q2 results reinforced the long-term bullish thesis, with adjusted EBITDA up 75% Y/Y to $415M as Rincón de Aranda and power generation drove performance. Rincón de Aranda is scaling rap
Silence Therapeutics' Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial
Silence Therapeutics NASDAQ: SLN reported top-line results from its Phase II SANRECO trial of divesiran in patients with phlebotomy-dependent polycythemia vera, or PV, with the study meeting its prima